Skip to main content
SpringerLink
Log in

Cytomegalovirus

  • Chapter
Intraocular Inflammation

Abstract

Cytomegalovirus is a ubiquitous herpes-family virus that infects the majority of the population at some point during their lifetime. About 60–70 % of the urban population in the United States and nearly 100 % of the population in some parts of Africa are infected. Transmission occurs during pregnancy or childbirth, during sexual contact, through exposure to bodily secretions (urine, feces, saliva, breast milk), through blood transfusions, or via organ transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Birnbaum AD, Tessler HH, Schultz KL, Farber MD, Gao W, Lin Oh F, Goldstein DA (2007) Epidemiologic relationship between Fuchs heterochromic iridocyclitis and the United States rubella vaccination program. Am J Ophthalmol 144(3):424–428

    Article  PubMed  Google Scholar 

  2. Boxtel LA, Lelij A, Meer J, Los LI (2007) Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology 114(7):1358–1362

    Article  PubMed  Google Scholar 

  3. Cheng L, Rao NA, Keefe KS et al (1998) Cytomegalovirus iritis. Ophthalmic Surg Lasers 29(11):930–993

    CAS  PubMed  Google Scholar 

  4. Chee SP, Bacsal K, Jap A et al (2007) Corneal endotheliitis associated with evidence of cytomegalovirus infection. Ophthalmology 114(4):798–803

    Article  PubMed  Google Scholar 

  5. Chee SP, Bacsal K, Jap A et al (2008) Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol 145(5):834–840

    Article  PubMed  Google Scholar 

  6. Holbrook JT, Jabs DA, Weinberg DV et al, for the Studies of Ocular Complications of AIDS (SOCA) Research Group (2003) Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy. Arch Ophthalmol 121(1):99–107

    Google Scholar 

  7. Holland GN, Tufail A, Jordan M (1996) Cytomegalovirus diseases. In: Pepose JS, Holland GN, Wilhelmus KR (eds) Ocular infection & immunity, vol 72. Mosby-Year Book Inc, St. Louis

    Google Scholar 

  8. Holland GN, Vaudaux JD, Jeng SM et al, for the UCLA CMV Retinitis Study Group (2008) Characteristics of untreated AIDS-related cytomegalovirus retinitis. I. Findings before the era of highly active antiretroviral therapy (1988 to 1994). Am J Ophthalmol 145(1):5–11

    Google Scholar 

  9. Holland GN, Vaudaux JD, Shiramizu KM et al, for the Southern California HIV/Eye Consortium (2008) Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000). Am J Ophthalmol 145(1):12–22

    Google Scholar 

  10. Hoover DR, Peng Y, Saah A et al (1996) Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol 114(7):821–827

    Article  CAS  PubMed  Google Scholar 

  11. Jabs DA (1995) Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc 93:623–683

    PubMed Central  CAS  PubMed  Google Scholar 

  12. Jabs DA (2004) AIDS and ophthalmology in 2004. Arch Ophthalmol 122(7):1040–1042

    Article  PubMed  Google Scholar 

  13. Jabs DA (2008) AIDS and ophthalmology, 2008. Arch Ophthalmol 126(8):1144–1146

    Article  Google Scholar 

  14. Jabs DA, Dunn JP, Enger C et al, for the Cytomegalovirus Retinitis and Viral Resistance Study Group (1996) Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Arch Ophthalmol 114(7):809–814

    Google Scholar 

  15. Jabs DA, Bolton SG, Dunn JP, Palestine AG (1998) Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy. Am J Ophthalmol 126(6):817–822

    Article  CAS  PubMed  Google Scholar 

  16. Jabs DA, Enger C, Dunn JP, Forman M, for the CMV Retinitis and Viral Resistance Study Group (1998) Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. J Infect Dis 177(3):770–773

    Google Scholar 

  17. Jabs DA, Enger C, Forman M, Dunn JP, for the Cytomegalovirus Retinitis and Viral Resistance Study Group (1998) Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. Antimicrob Agents Chemother 42(9):2240–2244

    Google Scholar 

  18. Jabs DA, Martin BK, Forman MS et al, for the Cytomegalovirus Retinitis and Viral Resistance Study Group (2001) Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: the Cytomegalovirus and Viral Resistance Study Group report number 8. Am J Ophthalmol 132(5):700–710

    Google Scholar 

  19. Jabs DA, Van Natta ML, Kempen JH et al (2002) Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol 133(1):48–61

    Article  PubMed  Google Scholar 

  20. Jabs DA, Martin BK, Forman MS et al, for the Cytomegalovirus Retinitis and Viral Resistance Study Group (2003) Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis. Am J Ophthalmol 135(1):26–34

    Google Scholar 

  21. Jabs DA, Van Natta ML, Thorne JE et al, for the Studies of Ocular Complications of AIDS Research Group (2004) Course of cytomegalovirus retinitis in the era of highly active antiretroviraltherapy: 1. retinitis progression. Ophthalmology 111(12):2224–2231

    Google Scholar 

  22. Jabs DA, Van Natta ML, Thorne JE et al, for the Studies of Ocular Complications of AIDS Research Group (2004) Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. second eye involvement and retinal detachment. Ophthalmology 111(12):2232–2239

    Google Scholar 

  23. Jabs DA, Martin BK, Ricks MO, Forman MS, for the Cytomegalovirus Retinitis and Viral Resistance Study Group (2006) Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: correlation of genotypic methods with viral phenotype and clinical outcome. J Infect Dis 193(12):1728–1737

    Google Scholar 

  24. Jabs DA, Van Natta ML, Holbrook JT et al (2007) Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology 114(4):780–786

    Article  PubMed  Google Scholar 

  25. Jabs DA, Van Natta ML, Holbrook JT et al (2007) Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology 114(4):787–793

    Article  PubMed  Google Scholar 

  26. Jacobson MA, Tan QX, Girling V, Poon C, Van Natta M, Jabs DA, Inokuma M, Maecker HT, Bredt B, Sinclair E, Studies of Ocular Complications of AIDS Research Group (2008) Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS. Clin Infect Dis 46(3):458–466

    Google Scholar 

  27. Kempen JH, Jabs DA, Wilson LA et al (2003) Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. Clin Infect Dis 37(10):1365–1373

    Article  PubMed  Google Scholar 

  28. Karavellas MP, Plummer DJ, Macdonald JC et al (1999) Incidence of immune recovery vitritis in cytomegalovirus patients following institution of successful highly active antiretroviral therapy. J Infect Dis 179(3):697–700

    Article  CAS  PubMed  Google Scholar 

  29. Kawaguchi T, Sugita S, Shimizu N, Mochizuki M (2007) Kinetics of aqueous flare, intraocular pressure, and virus-DNA copies in a patient with cytomegalovirus iridocyclitis without retinitis. Int Ophthalmol 27(6):383–386

    Article  PubMed  Google Scholar 

  30. Kempen JH, Min YI, Freeman WR et al, for the Studies of Ocular Complications of AIDS Research Group (2006) Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology 113(4):684–694

    Google Scholar 

  31. Kuo IC (2000) Ocular neovascularisation in patients with uveitis. Int Ophthalmol Clin 40(2):111–126

    Article  CAS  PubMed  Google Scholar 

  32. Kuo IC, Kempen JH, Dunn JP, Vogelsang G, Jabs DA (2004) Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. Am J Ophthalmol 138(3):338–346

    Article  PubMed  Google Scholar 

  33. Kuppermann BD, Holland GN (2000) Immune recovery uveitis. Am J Ophthalmol 130(1):103–106

    Article  CAS  PubMed  Google Scholar 

  34. Lalezari JP, Stagg RJ, Kuppermann BD et al (1997) Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS: a randomized, controlled trial. Ann Intern Med 126(4):257–263

    Article  CAS  PubMed  Google Scholar 

  35. Limaye AP, Kirby KA, Rubenfeld GD et al (2008) Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 300(4):413–422

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  36. Mandell GL, Bennett JE, Dolin R (2005) In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases, 6th edn. Churchill Livingstone Principles, New York

    Google Scholar 

  37. Markomichelakis NN, Canakis C, Zafirakis P et al (2002) Cytomegalovirus as a cause of anterior uveitis with sectoral iris atrophy. Ophthalmology 109(5):879–882

    Article  PubMed  Google Scholar 

  38. Martin DF, Kuppermann BD, Wolitz RA et al, for the Roche Ganciclovir Study Group (1999) Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. N Engl J Med 340(14):1063–1070

    Google Scholar 

  39. Martin DF, Sierra-Madero J, Walmsley S, et al, for the Valganciclovir Study Group (2002) A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med 346(15):1119–1126

    Google Scholar 

  40. Martin BK, Ricks MO, Forman MS, Jabs DA, for the Cytomegalovirus Retinitis and Viral Resistance Study Group (2007) Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis. Clin Infect Dis 44(7):1001–1008

    Google Scholar 

  41. Musch DC, Martin DF, Gordon JF, Davis MD, Kuppermann BD, for the Ganciclovir Implant Study Group (1997) Treatment of cytomegalovirus retinitis with a sustained release ganciclovir implant. N Engl J Med 337(2):83–90

    Google Scholar 

  42. Nguyen QD, Kempen JH, Bolton SG, Dunn JP, Jabs DA (2000) Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol 129(5):634–639

    Article  CAS  PubMed  Google Scholar 

  43. Nussenblatt RB, Lane HC (1998) Human immunodeficiency virus disease: changing patterns of intraocular inflammation. Am J Ophthalmol 125(3):374–382

    Article  CAS  PubMed  Google Scholar 

  44. Ortega-Larrocea G, Espinosa E, Reyes-Teran G (2005) Lower incidence and severity of cytomegalovirus-associated immune recovery uveitis in HIV-infected patients with delayed highly active antiretroviral therapy. AIDS 19(7):735–738

    Article  PubMed  Google Scholar 

  45. Palestine AG, Polis MA, DeSmet MD et al (1991) A randomized controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 115(9):665–673

    Article  CAS  PubMed  Google Scholar 

  46. Patel SS, Rutzen AR, Marx JL et al (1996) Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome. Visual prognosis of patients treated with ganciclovir and/or foscarnet. Ophthalmology 103(9):1476–1482

    Article  CAS  PubMed  Google Scholar 

  47. Quentin CD, Reiber H (2004) Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol 138(1):46–54

    Article  PubMed  Google Scholar 

  48. Rao NA, Zhang J, Ishimoto S (1998) Role of retinal vascular endothelial cells in development of CMV retinitis. Trans Am Ophthalmol Soc 96:111–123

    PubMed Central  CAS  PubMed  Google Scholar 

  49. Read RW, Zhang JA, Ishimoto SI, Rao NA (1999) Evaluation of the role of human retinal vascular endothelial cells in the pathogenesis of CMV retinitis. Ocul Immunol Inflamm 7(3–4):139–146

    Article  CAS  PubMed  Google Scholar 

  50. Schryver D, Rozenberg F, Cassoux N et al (2006) Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis. Br J Ophthalmol 90(7):852–855

    Article  PubMed Central  PubMed  Google Scholar 

  51. Sinclair E, Tan QX, Sharp M, Girling V, Poon C, Natta MV, Jabs DA, Inokuma M, Maecker HT, Bredt B, Jacobson MA, Studies of Ocular Complications of AIDS Research Group (2006) Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype. J Infect Dis 194(11):1537–1546

    Google Scholar 

  52. Spector SA, Weingeist T, Pollard RB et al (1993) A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS: AIDS Clinical Trials Group and Cytomegalovirus Study Group. J Infect Dis 168(3):557–563

    Article  CAS  PubMed  Google Scholar 

  53. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group (1994) Foscarnet-ganciclovir cytomegalovirus retinitis trial. 4. Visual outcomes. Ophthalmology 101(7):1250–1261

    Article  Google Scholar 

  54. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group (1997) Parenteral cidofovir (HPMPC) for cytomegalovirus retinitis in patients with AIDS: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. Ann Intern Med 126(4):264–274

    Article  Google Scholar 

  55. Thorne JE, Jabs DA, Kempen JH et al (2006) Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology 113(8):1432–1440

    Article  PubMed  Google Scholar 

  56. Thorne JE, Jabs DA, Kempen JH et al (2006) Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology 113(8):1441–1445

    Article  PubMed  Google Scholar 

  57. Thorne JE, Holbrook JT, Jabs DA et al (2007) Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS. Ophthalmology 114(3):591–598

    Article  PubMed  Google Scholar 

  58. Torriani FJ, Freeman WR, Macdonald JC et al (2000) CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy. AIDS 14(2):173–180

    Article  CAS  PubMed  Google Scholar 

  59. Van Gelder RN (2008) Idiopathic no more: clues to the pathogenesis of Fuchs heterochromic iridocyclitis and glaucomatocyclitic crisis. Am J Ophthalmol 145(5):769–771

    Article  PubMed  Google Scholar 

  60. Weinberg A, Jabs DA, Chou S et al, for the Cytomegalovirus Retinitis and Viral Resistance Study Group, for the Adult AIDS Clinical Trials Group Cytomegalovirus Laboratories (2003) Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. J Infect Dis 187(5):777–784

    Google Scholar 

  61. Whitcup SM, Fortin E, Lindblad AS et al (1999) Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis. J Am Med Assoc 282(17):1633–1637

    Article  CAS  Google Scholar 

  62. Yoser SL, Forster DJ, Rao NA (1993) Systemic viral infections and their retinal and choroidal manifestations. Surv Ophthalmol 37(5):313–352

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Mount Sinai School of Medicine, Mount Sinai Hospital, One Gustave L. Levy Place, Box 1183, New York, NY, 10029-6574, USA

    Ashish Toor MD & Douglas A. Jabs MD, MBA

  2. Department of Medicine, Mount Sinai School of Medicine, Mount Sinai Hospital, New York, NY, USA

    Douglas A. Jabs MD, MBA

Authors
  1. Ashish Toor MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Douglas A. Jabs MD, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Douglas A. Jabs MD, MBA .

Editor information

Editors and Affiliations

  1. Centre of Ophthalmology, University of Tuebingen, Tuebingen, Germany

    Manfred Zierhut

  2. Biomedical Research Centre, Institute of Ophthalmology, Moorfields Eyes Hospital, Department of Medical Retina, UCL, London, United Kingdom

    Carlos Pavesio

  3. School of Medicine, Department of Ophthalmology, Hokkaido University Graduate, Sapporo, Hokkaido, Japan

    Shigeaki Ohno

  4. University of Belo Horizonte, Belo Horizonte, Brazil

    Fernando Orefice

  5. USC Eye Institute, University of Southern California, Los Angeles, California, USA

    Narsing A. Rao

1 Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Case Report 84

CMV retinitis (PPTX 5187 kb)

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Toor, A., Jabs, D.A. (2016). Cytomegalovirus. In: Zierhut, M., Pavesio, C., Ohno, S., Orefice, F., Rao, N. (eds) Intraocular Inflammation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_107

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-75387-2_107

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-75385-8

  • Online ISBN: 978-3-540-75387-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation